[KLK] YoY TTM Result on 30-Jun-2020 [#3]

Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2020
Quarter
30-Jun-2020 [#3]
Profit Trend
QoQ- 76.44%
YoY- 35.81%
View:
Show?
TTM Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 24,846,980 26,107,303 17,984,671 15,394,951 15,922,460 19,373,306 20,383,215 3.35%
PBT 1,696,798 3,372,042 2,432,761 1,096,178 747,380 1,327,992 1,313,371 4.35%
Tax -336,783 -776,139 -437,065 -283,548 -187,935 -361,619 -110,535 20.39%
NP 1,360,015 2,595,903 1,995,696 812,630 559,445 966,373 1,202,836 2.06%
-
NP to SH 1,180,081 2,329,960 1,840,600 738,807 543,986 893,952 1,138,063 0.60%
-
Tax Rate 19.85% 23.02% 17.97% 25.87% 25.15% 27.23% 8.42% -
Total Cost 23,486,965 23,511,400 15,988,975 14,582,321 15,363,015 18,406,933 19,180,379 3.43%
-
Net Worth 14,461,826 13,509,295 12,047,315 10,752,433 10,489,912 11,235,388 11,341,884 4.13%
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 215,667 215,604 215,705 160,569 159,744 532,482 532,482 -13.97%
Div Payout % 18.28% 9.25% 11.72% 21.73% 29.37% 59.57% 46.79% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 14,461,826 13,509,295 12,047,315 10,752,433 10,489,912 11,235,388 11,341,884 4.13%
NOSH 1,081,017 1,081,017 1,081,017 1,081,017 1,064,965 1,064,965 1,064,965 0.24%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 5.47% 9.94% 11.10% 5.28% 3.51% 4.99% 5.90% -
ROE 8.16% 17.25% 15.28% 6.87% 5.19% 7.96% 10.03% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 2,303.98 2,421.48 1,667.50 1,427.47 1,495.11 1,819.15 1,913.98 3.13%
EPS 109.43 216.11 170.66 68.50 51.08 83.94 106.86 0.39%
DPS 20.00 20.00 20.00 15.00 15.00 50.00 50.00 -14.15%
NAPS 13.41 12.53 11.17 9.97 9.85 10.55 10.65 3.91%
Adjusted Per Share Value based on latest NOSH - 1,081,017
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 2,260.90 2,375.58 1,636.48 1,400.83 1,448.83 1,762.83 1,854.73 3.35%
EPS 107.38 212.01 167.48 67.23 49.50 81.34 103.56 0.60%
DPS 19.62 19.62 19.63 14.61 14.54 48.45 48.45 -13.98%
NAPS 13.1592 12.2925 10.9622 9.784 9.5451 10.2234 10.3203 4.13%
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 21.96 21.94 20.36 22.20 24.56 24.16 24.88 -
P/RPS 0.95 0.91 1.22 1.56 1.64 1.33 1.30 -5.09%
P/EPS 20.07 10.15 11.93 32.41 48.08 28.78 23.28 -2.44%
EY 4.98 9.85 8.38 3.09 2.08 3.47 4.30 2.47%
DY 0.91 0.91 0.98 0.68 0.61 2.07 2.01 -12.36%
P/NAPS 1.64 1.75 1.82 2.23 2.49 2.29 2.34 -5.74%
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/08/23 17/08/22 18/08/21 19/08/20 20/08/19 14/08/18 15/08/17 -
Price 22.40 23.00 19.88 22.60 23.82 24.86 24.68 -
P/RPS 0.97 0.95 1.19 1.58 1.59 1.37 1.29 -4.63%
P/EPS 20.47 10.64 11.65 32.99 46.63 29.62 23.09 -1.98%
EY 4.89 9.40 8.58 3.03 2.14 3.38 4.33 2.04%
DY 0.89 0.87 1.01 0.66 0.63 2.01 2.03 -12.83%
P/NAPS 1.67 1.84 1.78 2.27 2.42 2.36 2.32 -5.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment